What question did this study set out to answer?

To update the Canadian Rheumatology Association guidelines for rheumatoid arthritis treatment, particularly focusing on DMARD management.

April 3, 2026The Journal of Rheumatology0 citations

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3

RNRoko P.A. Nikolic AAArnav Agarwal JPJordi Pardo Pardo

Key Points

To update the Canadian Rheumatology Association guidelines for rheumatoid arthritis treatment, particularly focusing on DMARD management.
Reviewed existing recommendations regarding DMARDs.
Expanded recommendations to include dosing strategies for conventional, targeted, and biologic DMARDs.
Incorporated clinical feedback and recent evidence.
Introduced new guidelines for dose reduction and tapering of DMARDs.
Provided clearer strategies for discontinuation of various DMARD types.
Improved recommendations to enhance patient management and treatment outcomes.

Abstract

We have updated the Canadian Rheumatology Association (CRA) guidelines for rheumatoid arthritis (RA) with a significant addition and expansion to an existing recommendation addressing the dose reduction/tapering and discontinuation of disease-modifying antirheumatic drugs (DMARDs). New recommendations now encompass conventional synthetic, targeted synthetic, and biologic DMARDs.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper